Micro-RNA-dependent regulation of the UPR
Micro-RNA-dependent regulation of the UPR
批准号:
8596329
负责人:
John Alan Diehl
金额:
$30.88万
依托单位国家:
美国
项目类别:
财政年份:
2013
资助国家:
美国
项目状态:
已结题
起止时间:
2013-09-18 至 2018-08-31
关键词:
ApoptosisApoptoticAttenuatedBase PairingBiologicalBiological ProcessCell CycleCell Cycle ProgressionCell DeathCell SurvivalCellsChemosensitizationChromatinCollaborationsCyclin D1DefectDevelopmentEndoplasmic ReticulumEnzymesEquilibriumFoundationsFunctional RNAGene ExpressionGenesGenetic TranslationGlucoseGoalsGrowthGrowth FactorHomeostasisIFNAR1 geneInstructionIntegral Membrane ProteinInterferonsIntronsMalignant NeoplasmsMammalian CellMediatingMediator of activation proteinMetabolicMicroRNAsMolecularMolecular ChaperonesNormal CellNucleotidesNutrientOncogenicOrganellesOrganismOutcomeOxidation-ReductionOxidative StressOxygenPathway interactionsPhosphotransferasesPlayProliferatingProtein KinaseProteinsRNARegulationRoleSignal PathwaySignal TransductionStressStructureTestingTissuesTransducersTranslationsTumor VolumeTumor-DerivedVirus DiseasesWorkbiological adaptation to stresscancer cellcancer therapycell growthdeprivationdesignendoplasmic reticulum stressglucose metabolisminhibitor/antagonistinsightinterestmRNA Transcript Degradationmammalian genomeneoplastic cellnovelpreventprotein misfoldingprotein transportresponsesmall moleculestemtranscription factortranscription factor CHOPtumor growthtumor progressiontumorigenesisubiquitin-protein ligase
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Rapidly proliferating cancer cells must thrive in a microenvironment wherein metabolic nutrients such as
glucose, oxygen and growth factors become limiting as tumor volume expands beyond the established
vascularity of the tissue. In normal cells, limits in nutrient availability trigger growth arrest and/or apoptosis,
thereby preventing cellular expansion under such conditions. The goal of this proposal is to determine the
role of the endoplasmic reticulum stress response/Unfolded Protein Response (UPR) in sensing limitations in
glucose availability, and thereby facilitating cellular adaptation. PERK, one of three proximal signal
transducers of the UPR, plays a central role in mediating cell fate decisions; this kinase has recently been
demonstrated to function in the potentiation of tumor growth and survival. Central to our understanding of
PERK-dependent survival is dissecting the significance of PERK pro-survival signaling through ATF4 versus
PERK-dependent apoptotic signals through the induction of CHOP. Critically, how pro-survival signals are
balanced with the induction of the pro-apoptotic transcription factor, CHOP, has remained poorly understood
for over a decade. Our preliminary work suggests an overarching hypothesis that temporal regulation of miR-
211 coordinates cellular adaptation with apoptosis in cells exposed to endoplasmic reticulum stress. To test
this hypothesis we will 1) determine the mechanisms of ER stress-dependent induction of miR-211
accumulation; 2) elucidate the mechanism(s) that regulate miR-211 stability; and 3) determine the role of
miR-211 in tumorigenesis. These studies will provide critical new insight into the mechanisms whereby the
PERK protein kinase regulates cell homeostasis in response to stress. There are obvious points of cross-
talk between this proposal and Project 2 which focuses on how the UPR antagonizes myc induced apoptosis
and potentiates tumor cell adaptation. Through collaboration with Project 2, we will assess the role of m|R-
211 as a mediator of cell growth and survival in myc-dependent tumorigenesis. Project 1 intersects with
Project 3 through common interests on how PERK regulates IFNAR1, the IFNAR1 E3 ligase and IFNAR1
signaling during tumorigenesis. Through collaboration with Project 3, we will detrmine how miR-211
regulates IFNAR1 regulation during ER stress and tumorigenesis as well as assess miR-211 regulation of
downstream interferon signaling. The.findings steming from the work proposed herein will provide a
foundation for the design of novel anti-cancer therpeutics.
RELEVANCE (See instructions):
Recent work has revealed that inactivation of PERK promotes tumor progression, providing support for the
development of small molecule inhibitors of PERK for cancer treatment. While these studies provide clear
biological support for such approaches, our understanding of how PERK regulates cell survival versus '
apoptosis following oncogenic insult is limited. The work described in this project will delineate molecular
mechanisms whereby PERK regulates the temporal onset of apoptosis.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Regulation of cell homeostasis by fbx4
-
批准号:8964361
-
项目类别:
-
资助金额:$22.53万
-
财政年份:2014
-
负责人:John Alan Diehl
-
依托单位:
Project 1- Micro-RNA-dependent signaling by the UPR
-
批准号:10247660
-
项目类别:
-
资助金额:$29.17万
-
财政年份:2013
-
负责人:John Alan Diehl
-
依托单位:
Project 1- Micro-RNA-dependent signaling by the UPR
-
批准号:10017913
-
项目类别:
-
资助金额:$29.17万
-
财政年份:2013
-
负责人:John Alan Diehl
-
依托单位:
Regulation of cell homeostasis by fbx4
-
批准号:8145722
-
项目类别:
-
资助金额:$36.23万
-
财政年份:2010
-
负责人:John Alan Diehl
-
依托单位:
Regulation of cell homeostasis by fbx4
-
批准号:7941448
-
项目类别:
-
资助金额:$16.6万
-
财政年份:2010
-
负责人:John Alan Diehl
-
依托单位:
Regulation of cell homeostasis by fbx4
-
批准号:8611904
-
项目类别:
-
资助金额:$11.03万
-
财政年份:2010
-
负责人:John Alan Diehl
-
依托单位:
Regulation of cell homeostasis by fbx4
-
批准号:8446158
-
项目类别:
-
资助金额:$34.06万
-
财政年份:2010
-
负责人:John Alan Diehl
-
依托单位:
Regulation of cell homeostasis by fbx4
-
批准号:8223243
-
项目类别:
-
资助金额:$36.23万
-
财政年份:2010
-
负责人:John Alan Diehl
-
依托单位:
Cyclin D1 and mammary carcinoma
-
批准号:7007686
-
项目类别:
-
资助金额:$29.95万
-
财政年份:2005
-
负责人:John Alan Diehl
-
依托单位:
Cyclin D1 and mammary carcinoma
-
批准号:6851131
-
项目类别:
-
资助金额:$30.68万
-
财政年份:2005
-
负责人:John Alan Diehl
-
依托单位:
Cyclin D1 and mammary carcinoma
-
批准号:7546563
-
项目类别:
-
资助金额:$29.09万
-
财政年份:2005
-
负责人:John Alan Diehl
-
依托单位:
Cyclin D1 and mammary carcinoma
-
批准号:7334751
-
项目类别:
-
资助金额:$29.09万
-
财政年份:2005
-
负责人:John Alan Diehl
-
依托单位:
Cyclin D1 and mammary carcinoma
-
批准号:7154794
-
项目类别:
-
资助金额:$29.09万
-
财政年份:2005
-
负责人:John Alan Diehl
-
依托单位:
Regulation of Tumorigenesis by the Perk Kinase
-
批准号:8382057
-
项目类别:
-
资助金额:$37.0万
-
财政年份:2004
-
负责人:John Alan Diehl
-
依托单位:
Regulation of Tumorigenesis by the Perk Kinase
-
批准号:8539279
-
项目类别:
-
资助金额:$35.63万
-
财政年份:2004
-
负责人:John Alan Diehl
-
依托单位:
Regulation of Tumorigenesis by the Perk Kinase
-
批准号:9350164
-
项目类别:
-
资助金额:$25.86万
-
财政年份:2004
-
负责人:John Alan Diehl
-
依托单位:
ER STRESS AS EARLY SENSOR OF NUTRIENT DEPRIVATION
-
批准号:6990452
-
项目类别:
-
资助金额:$18.03万
-
财政年份:2004
-
负责人:John Alan Diehl
-
依托单位:
Regulation of Tumorigenesis by the Perk Kinase
-
批准号:7713798
-
项目类别:
-
资助金额:$35.86万
-
财政年份:2004
-
负责人:John Alan Diehl
-
依托单位:
Regulation of Tumorigenesis by the Perk Kinase
-
批准号:8327682
-
项目类别:
-
资助金额:$36.95万
-
财政年份:2004
-
负责人:John Alan Diehl
-
依托单位:
Regulation of Tumorigenesis by the Perk Kinase
-
批准号:8742522
-
项目类别:
-
资助金额:$26.14万
-
财政年份:2004
-
负责人:John Alan Diehl
-
依托单位:
海外基金